how much is zealthy semaglutide Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity Zealthy GLP-1 Weight Loss Program

As clinical data and public discussion intersect, these launches are rewriting every rule in pharma marketing commanding broad consumer attention, setting new standards for adoption speed, and (perhaps most importantly) reshaping eXpectations around how life sciences brands engage, educate, and []

Three quarters of obese patients expressed an interest in a trial of a licensed weight loss medication as an adjunct to conventional IBD therapy

GLP-1, a hormone secreted by the intestines, lowers blood glucose and promotes weight loss through multiple mechanisms: it enhances insulin secretion in a glucose concentration-dependent manner, suppresses glucagon release, delays gastric emptying, and reduces food intake via central appetite suppression

GLP-1 short-term use explained: what happens when you stop, appetite changes, weight regain risk, and how to maintain results after Mounjaro or Wegovy.

12,000 crore market opportunity, which Indian pharma companies are leading, and what it means for your pharma portfolio.